Image

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This study is a prospective, multicentric, observational test negative design study on adults hospitalized for Severe Acute Respiratory Infection (SARI), regardless of their vaccination status.

Description

Participation to the study will be systematically proposed to all patients hospitalized fitting inclusion criteria. Patient's screening will be done in emergency department or hospital department with direct admission. Medical investigators explain the objectives of the studies, procedure and propose the patient to participate in the study. Socio-demographic data, clinical and virological data will be collected in an electronic clinical research form.

A follow-up at 1 and 3 months after hospitalization discharge will be scheduled to evaluate health status.

The remainder of respiratory samples that have been performed for care will be used for further testing depending on epidemiological situation and will be stored at -80°C.

Eligibility

Inclusion Criteria:

  • Age ≥ 18 years old
  • Admitted in a hospital for at least 24 h
  • Presents SARI criteria within onset within the last 14 days before sampling and less than 48 h after hospitalisations:
        At least one of the following signs (without treatment): fever or feverishness, malaise,
        headache, myalgia or sign of fatigue (loss of weight or anorexia or confusion or dizziness)
        Associated with at least one respiratory symptom or sign (cough, sore throat or shortness
        of breath; or tachypnoea or signs of low oxygen saturation)
          -  completed non-opposition form
          -  Respiratory samples within 14 days after symptoms onset, in the context of care
        Exclusion Criteria:
          -  Contraindication of vaccination

Study details

Severe Acute Respiratory Infection (SARI), Influenza, COVID-19

NCT05582239

ANRS, Emerging Infectious Diseases

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.